Stanford University
Showing 21,641-21,660 of 36,307 Results
-
Dinesh D Moorjani
Student, Program-Jain, R.
BioDinesh Moorjani is a serial tech founder & CEO, venture capital investor, and professor. He is the founder and Managing Partner of Time Zero Capital, a technology venture capital firm investing in responsible innovation.
Dinesh founded Hatch Labs Inc. where he served as Chairman & CEO and cofounded Tinder (NASDAQ: MTCH) in 2012. Dinesh built several technology companies including Saffronart, a global eCommerce marketplace for Indian fine art and collectibles backed by Sequoia Capital, where he continues to serve on the board. Dinesh also cofounded Kleverbeast—a no-code SaaS application development platform and Monet Analytics—an AI platform that decodes human emotion.
Dinesh served in numerous executive leadership roles at multinational corporations, including as Managing Director at Comcast Ventures, Sr. Vice President and Group Head of Mobility at IAC/InterActive Corp, and in various leadership roles at Samsung Electronics in the US and Asia. He built his early career in the Global Energy Practice at AD Little, Goldman Sachs, and as an early employee at Mainspring (IPO 2000, acquired by IBM 2001). Dinesh served as an independent board director at Alight (NYSE: ALIT) and on the advisory boards of Fortune 500 companies including American Express, Assurant, and Cox Automotive. He served on the board of directors of Zoox (acquired by Amazon), a leader in autonomous vehicles. Dinesh served as an advisor to Warburg Pincus, the global private equity firm, where he was previously an EIR, co-investing alongside the firm and serving in a governance capacity on portfolio company boards.
Dinesh is an adjunct professor at the UCLA Anderson School of Management, and regularly guest lectures at Harvard, Stanford, and MIT. Dinesh also serves on the Harvard Business School California Research Center Advisory Board. He supports disenfranchised youth and education through his non-profit work as a board director at the United Friends of the Children and the Organization for Social Media Safety. Dinesh continues to serve as a Board Trustee at the University of California, Merced. Dinesh earned his BS in Chemical Engineering from Northwestern University and MBA from Harvard. Dinesh is a PhD Candidate in the Engineering Department at Stanford University. -
Rudolf Moos
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsOur research group works primarily on psychiatric program evaluation and the quality of health care. The studies focus heavily on health care programs and the context, process, outcome, and cost of care.
-
Davíd Morales
Ph.D. Student in Education, admitted Autumn 2020
Current Research and Scholarly InterestsDavíd's research examines the pedagogical contributions of social movements and education activists, as well as their responses to colonial, (neo)liberal, and militarized logics that govern schools and racialized geographies across the U.S. and Latin America.
-
Esmeralda Morales
Clinical Associate Professor, Pediatrics - Pulmonary Medicine
BioEsmeralda Morales, MD is a Board-Certified Pediatric Pulmonologist who earned her medical degree from Baylor College of Medicine. She completed her subspecialty training in Pediatric Pulmonology at the University of Arizona/Arizona Respiratory Center known for its excellence in asthma care and research. She practiced in the southwestern United States for 7 years including a year as Interim Chief of the Pediatric Pulmonary Division at the University of New Mexico and was a former University of New Mexico Cystic Fibrosis Center Director, as well as co-chair of the New Mexico Council on Asthma. She has been a member of the Pediatric Pulmonary Division through the Stanford University School of Medicine for the past 7 years and is leading asthma clinical efforts in the division. Her main areas of interest are childhood asthma, aerodigestive disorders in children, respiratory disorders in children with complex healthcare needs and the care of historically marginalized patient populations.
